Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Celladon Corporation Company Profile

20:40 EDT 19th April 2014 | BioPortfolio

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The company’s products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladon’s first product candidate, MYDICAR®, delivers the gene for the SERCA2a enzyme and is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladon’s website at www.celladon.net.

Location

2223 Avenida de la Playa #206
La Jolla
California
92037
United States of America

Contact

Phone: 858.366.4288
Fax: 858.964.0974
Email: info@celladon.net


News Articles [42 Associated News Articles listed on BioPortfolio]

Stifel starts Celladon at buy

Stifel Nicolas has initiated coverage of Celladon (NASDAQ:CLDN) with a “buy” rating and $16 target price. The stock is trading up 45% at $10.90 in heavy turnover on Monday afternoon. Celladon’s...

Servier gets option to SERCA2b modulators from Celladon

One month after going public, Celladon Corp. (calcium dysregulation therapeutics) licensed Servier SA an exclusive option to worldwide rights--excluding the US where Celladon retains rights--to precli...

Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene Therapy

The FDA has granted its “breakthrough therapy” designation for a gene therapy treatment in mid-stage development by San Diego’s Celladon (NASDAQ: CLDN), for patients with advanced heart failure....

Celladon gains on Servier option

Celladon Corp. (NASDAQ:CLDN) jumped as much as 94% on Monday before closing the day up $1.93 (26%) to $9.50 after granting Servier (Neuilly-sur-Seine, France) an exclusive option to license ex-U.S. ri...

Celladon revives IPO plans

NASDAQ IPO plans for Celladon Corp. (San Diego, Calif.) now seem to be on track. The gene therapy company postponed its IPO in November, citing market conditions. On Wednesday, Celladon filed an S-1A...

Celladon files for IPO then postpones offer

Celladon Corp. (calcium dysregulation therapeutics) filed for an IPO on Nasdaq. The company targets SERCA enzymes--known to play a role in regulating calcium in human cells--to create both gene therap...

Celladon postpones IPO

Gene therapy company Celladon Corp. (San Diego, Calif.) postponed its IPO, citing market conditions. Earlier this month, the company amended its IPO and said it planned to sell 5 million shares at $14...

Two months after postponing offer, Celladon nets $40.9mm in refiled Nasdaq IPO

Celladon Corp. (calcium dysregulation therapeutics) completed a $40.9mm IPO, selling 5.5mm shares at $8, a steep decline from its proposed $14-16 range announced in November 2013, shortly before it po...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Celladon Corp.

Celladon Corp., based in La Jolla, Calif., was launched in October 2004 as a privately held biotechnology company with the goal of becoming the leader in developing molecular therapies for the treatme...

Celladon Corporation

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in develop...

More Information about "Celladon Corporation" on BioPortfolio

We have published hundreds of Celladon Corporation news stories on BioPortfolio along with dozens of Celladon Corporation Clinical Trials and PubMed Articles about Celladon Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celladon Corporation Companies in our database. You can also find out about relevant Celladon Corporation Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement